COMMUNIQUÉS West-GlobeNewswire

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

12/04/2018 - 13:00

Long-Term Safety and Efficacy Data in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome to be Presented LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) “GW,” “the Company” or “ [...]

Trillium Therapeutics to Report Preclinical Data on TTI-621 and TTI-622 at the AACR Annual Meeting 2018

12/04/2018 - 13:00

TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq: TRIL ) (TSX: TRIL ) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced [...]

Aeglea BioTherapeutics Presents New Phase 1/2 Trial Data Demonstrating Clinically Relevant Treatment Effects in Arginase 1 Deficiency Patients at the 2018 ACMG Annual Clinical Genetics Meeting

12/04/2018 - 13:00

Clinical Outcome Assessment Tools Detected and Quantified Baseline Abnormalities Clinically Relevant Improvement Seen in Multiple Neuromotor Tests Company to Host Clinical Update Conference Call Today at 8:30 a.m. ET [...]

Capricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor Day

12/04/2018 - 13:00

LOS ANGELES, April 12, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will be among the companies providing presentations at the Alliance for Regenerative Medicine’s (ARM’s) [...]

Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases

12/04/2018 - 13:00

– Phase 3 IGNITE4 Results in Complicated Intra-Abdominal Infection Recognized as a ‘Best Rated Abstract’ – – Other Key Eravacycline and TP-6076 Data to Also be Highlighted – WATERTOWN, Mass., April 12, 2018 (GLOBE [...]

Microbot Medical’s Self-Cleaning Shunt Awarded a Grant by the European Commission

12/04/2018 - 13:00

Non-Dilutive Grant Strengthens Balance Sheet for Further Milestone Achievements HINGHAM, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in the [...]

EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™

12/04/2018 - 13:00

WATERTOWN, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT ) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic [...]

Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test

12/04/2018 - 13:00

THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces the engagement of [...]

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides

12/04/2018 - 11:00

BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

iTeos Therapeutics to Present Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR

12/04/2018 - 09:37

iTeos Therapeutics to Present Preclinical Data from A 2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Gosselies, Belgium - April 12, 2018 - iTeos Therapeutics SA, a biotechnology company developing novel [...]

Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care

12/04/2018 - 09:30

Helsinn Provides Grant for ESMO's Preceptorship Programme for Supportive and Palliative Care Lugano, Switzerland April 12, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, [...]

Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference

12/04/2018 - 09:10

Robust antiviral activity observed in HBV patients Generally safe and well tolerated Planning underway for Phase 2a studies beginning summer 2018 Company to host conference call on Thursday, April 12 th at 8am ET / 2pm [...]

Medibio finalizes acquisition of Vital Conversations

12/04/2018 - 09:00

SYDNEY, Australia and MINNEAPOLIS, April 12, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces the completion of the acquisition of [...]

Shire plc : Rule 2.9 Announcement

12/04/2018 - 08:34

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 April 2018 [...]

CellaVision AB: CellaVision's 2017 Annual report now available

12/04/2018 - 08:22

Today, CellaVision announced that the company's Annual report for 2017 is available as PDF at www.cellavision.com , and can be read via the link below. The company has decided to print CellaVisions 2017 Annual report in [...]

Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam

12/04/2018 - 08:15

Press release - No. 10 / 2018 Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam Copenhagen, April 12, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer ( [...]

Infant Bacterial Therapeutics publishes Annual Report for 2017

12/04/2018 - 08:01

Today, Infant Bacterial Therapeutics AB (publ) publishes the Annual Report for the financial year 2017. The report is available on IBTs website under financial information http://ibtherapeutics.com/investors/financial- [...]

ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018

12/04/2018 - 07:30

LYON, France, April 12, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]

Sensorion reports full year 2017 results

12/04/2018 - 07:30

Increase in operating costs consistent with advancing clinical development of SENS-111 for acute unilateral vestibulopathy (severe vertigo) and SENS-401 for sudden sensorineural hearing loss; Validating deal to study [...]